טוען...
Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy
Current cancer therapies have encountered adverse response due to poor therapeutic efficiency, severe side effects and acquired resistance to multiple drugs. Thus, there are urgent needs for finding new cancer-targeted pharmacological strategies. In this review, we summarized the current understandi...
שמור ב:
| הוצא לאור ב: | Chronic Dis Transl Med |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Chinese Medical Association
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6926117/ https://ncbi.nlm.nih.gov/pubmed/31891127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2019.08.006 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|